Cargando…

Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth

OBJECTIVE: Patients with small intestine bacterial overgrowth (SIBO) have chronic intestinal and extraintestinal symptomatology which adversely affects their quality of life. Present treatment of SIBO is limited to oral antibiotics with variable success. A growing number of patients are interested i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chedid, Victor, Dhalla, Sameer, Clarke, John O., Roland, Bani Chander, Dunbar, Kerry B., Koh, Joyce, Justino, Edmundo, Tomakin, Eric, Mullin, Gerard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Advances in Health and Medicine 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030608/ https://www.ncbi.nlm.nih.gov/pubmed/24891990 http://dx.doi.org/10.7453/gahmj.2014.019

Ejemplares similares

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
por: Konrad, Paulina, et al.
Publicado: (2018)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
por: Gatta, L., et al.
Publicado: (2017)

Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change
por: Lee, Seok-Hoon, et al.
Publicado: (2019)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

The Role of the Gut Microbiome in the Pathogenesis and Treatment of Obesity
por: Okeke, Francis, et al.
Publicado: (2014)

Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth—A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin
por: Chojnacki, Cezary, et al.
Publicado: (2021)

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
por: Guo, Huaizhu, et al.
Publicado: (2023)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Nutrient Challenge Testing Is Not Equivalent toScintigraphy−Lactulose Hydrogen Breath Testing inDiagnosing Small Intestinal Bacterial Overgrowth
por: Schindler, Valeria, et al.
Publicado: (2020)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Chinese herbal medicine for the treatment of small intestinal bacterial overgrowth (SIBO): A protocol for systematic review and meta-analysis
por: Ren, Xuetong, et al.
Publicado: (2020)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort
por: Plauzolles, Anne, et al.
Publicado: (2022)

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
por: Shen, Bo, et al.
Publicado: (2008)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
por: Ridola, Lorenzo, et al.
Publicado: (2013)

Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
por: Rezigh, Alec B., et al.
Publicado: (2018)

Rifaximin has the potential to prevent complications of cirrhosis
por: Flamm, Steven L., et al.
Publicado: (2018)

Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Piccin, Anna, et al.
Publicado: (2023)

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Bioactive Equivalence of Combinatorial Components Identified in Screening of an Herbal Medicine
por: Liu, Peng, et al.
Publicado: (2014)

Bacterial translocation consequential to intestinal bacterial overgrowth provokes aggravation of mortality by sepsis
por: Menchaca-Diaz, JL, et al.
Publicado: (2003)

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice
por: Zhang, Shengyan, et al.
Publicado: (2023)

Small intestinal bacterial overgrowth syndrome in children
por: Siniewicz-Luzeńczyk, Katarzyna, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth in Alzheimer’s disease
por: Kowalski, Karol, et al.
Publicado: (2021)

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
por: Kimer, Nina, et al.
Publicado: (2014)

Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans
por: Finlin, Brian S, et al.
Publicado: (2019)

Lactulose/rifaximin: Lack of drug effect: case report
Publicado: (2021)

Probing gut‐brain links in Alzheimer's disease with rifaximin
por: Suhocki, Paul V., et al.
Publicado: (2022)

Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy
por: Jesudian, Arun B., et al.
Publicado: (2020)

The Overgrowth of Surgery in Gynæcology
Publicado: (1886)

Link between hypothyroidism and small intestinal bacterial overgrowth
por: Patil, Anant D.
Publicado: (2014)

The duodenal microbiome is altered in small intestinal bacterial overgrowth
por: Leite, Gabriela, et al.
Publicado: (2020)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffvdav9g24luevf291mfh2fh4t